Company registration number SC442264 (Scotland)
NUANCE HEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
PAGES FOR FILING WITH REGISTRAR
NUANCE HEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
NUANCE HEALTHCARE LIMITED
BALANCE SHEET
AS AT
31 MARCH 2024
31 March 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
4
662,659
655,892
Current assets
Stocks
33,087
22,561
Debtors
5
30,678
29,597
Cash at bank and in hand
108,393
88,119
172,158
140,277
Creditors: amounts falling due within one year
6
(167,417)
(138,599)
Net current assets
4,741
1,678
Total assets less current liabilities
667,400
657,570
Creditors: amounts falling due after more than one year
7
(363,771)
(423,732)
Provisions for liabilities
(68,258)
(64,295)
Net assets
235,371
169,543
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
235,271
169,443
Total equity
235,371
169,543

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

NUANCE HEALTHCARE LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2024
31 March 2024
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 24 September 2024 and are signed on its behalf by:
Ms S Kerk
Director
Company registration number SC442264 (Scotland)
NUANCE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
- 3 -
1
Accounting policies
Company information

Nuance Healthcare Limited is a private company limited by shares incorporated in Scotland. The registered office is 3 George Square, Castle Brae, Dunfermline, Fife, KY11 8QF.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements

1.3
Turnover

Turnover represents amounts receivable for dental services.

 

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Land and buildings
2% - Straight Line
Plant and machinery
10% - 25% Straight Line
Fixtures, fittings & equipment
10% - 25% Straight Line
Computer equipment
33 1/3% Straight Line
Motor vehicles
25% Reducing Balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

NUANCE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 4 -

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

NUANCE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 5 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Where material deferred taxation is provided on the liability method to take account of timing differences between the treatment of certain items for accounts purposes and their treatment for tax purposes.

 

Tax deferred or accelerated is accounted for in respect of all material timing differences.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement where material is recognised in the period in which the employee’s services are received.

 

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

NUANCE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 6 -

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.14
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was 11 (2023 - 10).

2024
2023
Number
Number
Total
11
10
NUANCE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 7 -
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 April 2023
501,163
397,533
898,696
Additions
-
0
85,706
85,706
Disposals
-
0
(1,936)
(1,936)
At 31 March 2024
501,163
481,303
982,466
Depreciation and impairment
At 1 April 2023
60,138
182,666
242,804
Depreciation charged in the year
10,023
67,948
77,971
Eliminated in respect of disposals
-
0
(968)
(968)
At 31 March 2024
70,161
249,646
319,807
Carrying amount
At 31 March 2024
431,002
231,657
662,659
At 31 March 2023
441,025
214,867
655,892
5
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
8,805
6,499
Other debtors
21,873
23,098
30,678
29,597
6
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
67,703
88,710
Taxation and social security
46,351
13,326
Other creditors
53,363
36,563
167,417
138,599
7
Creditors: amounts falling due after more than one year
2024
2023
£
£
Other creditors
363,771
423,732
NUANCE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 8 -
8
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2024
2023
£
£
708
708
2024-03-312023-04-01false24 September 2024CCH SoftwareCCH Accounts Production 2024.200No description of principal activityMrs S KerkMr P RobertsonfalsefalseSC4422642023-04-012024-03-31SC4422642024-03-31SC4422642023-03-31SC442264core:LandBuildings2024-03-31SC442264core:OtherPropertyPlantEquipment2024-03-31SC442264core:LandBuildings2023-03-31SC442264core:OtherPropertyPlantEquipment2023-03-31SC442264core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-31SC442264core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-31SC442264core:Non-currentFinancialInstrumentscore:AfterOneYear2024-03-31SC442264core:Non-currentFinancialInstrumentscore:AfterOneYear2023-03-31SC442264core:CurrentFinancialInstruments2024-03-31SC442264core:CurrentFinancialInstruments2023-03-31SC442264core:ShareCapital2024-03-31SC442264core:ShareCapital2023-03-31SC442264core:RetainedEarningsAccumulatedLosses2024-03-31SC442264core:RetainedEarningsAccumulatedLosses2023-03-31SC442264bus:Director12023-04-012024-03-31SC442264core:LandBuildingscore:OwnedOrFreeholdAssets2023-04-012024-03-31SC442264core:PlantMachinery2023-04-012024-03-31SC442264core:FurnitureFittings2023-04-012024-03-31SC442264core:ComputerEquipment2023-04-012024-03-31SC442264core:MotorVehicles2023-04-012024-03-31SC4422642022-04-012023-03-31SC442264core:LandBuildings2023-03-31SC442264core:OtherPropertyPlantEquipment2023-03-31SC4422642023-03-31SC442264core:LandBuildings2023-04-012024-03-31SC442264core:OtherPropertyPlantEquipment2023-04-012024-03-31SC442264core:WithinOneYear2024-03-31SC442264core:WithinOneYear2023-03-31SC442264core:Non-currentFinancialInstruments2024-03-31SC442264core:Non-currentFinancialInstruments2023-03-31SC442264bus:PrivateLimitedCompanyLtd2023-04-012024-03-31SC442264bus:SmallCompaniesRegimeForAccounts2023-04-012024-03-31SC442264bus:FRS1022023-04-012024-03-31SC442264bus:AuditExemptWithAccountantsReport2023-04-012024-03-31SC442264bus:Director22023-04-012024-03-31SC442264bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:sharesiso4217:GBP